The SWI/SNF Chromatin Remodeling Complex Regulates Myocardin-induced Smooth Muscle-specific Gene Expression
Overview
Authors
Affiliations
Objective: Regulatory complexes comprising myocardin and serum response factor (SRF) are critical for the transcriptional regulation of many smooth muscle-specific genes. However, little is known about the epigenetic mechanisms that regulate the activity of these complexes. In the current study, we investigated the role of SWI/SNF ATP-dependent chromatin remodeling enzymes in regulating the myogenic activity of myocardin.
Methods And Results: We found that both Brg1 and Brm are required for maintaining expression of several smooth muscle-specific genes in primary cultures of aortic smooth muscle cells. Furthermore, the ability of myocardin to induce expression of smooth muscle-specific genes is abrogated in cells expressing dominant negative Brg1. In SW13 cells, which lack endogenous Brg1 and Brm1, myocardin is unable to induce expression of smooth muscle-specific genes. Whereas, reconstitution of wild-type, or bromodomain mutant forms Brg1 or Brm1, into SW13 cells restored their responsiveness to myocardin. SWI/SNF complexes were found to be required for myocardin to increase SRF binding to the promoters of smooth muscle-specific genes. Brg1 and Brm directly bind to the N terminus of myocardin, in vitro, through their ATPase domains and Brg1 forms a complex with SRF and myocardin in vivo in smooth muscle cells.
Conclusions: These data demonstrate that the ability of myocardin to induce smooth muscle-specific gene expression is dependent on its interaction with SWI/SNF ATP-dependent chromatin remodeling complexes.
Jeon J, Lee S, Park H, Park Y, Kim T, Lee S Int J Mol Sci. 2024; 25(21).
PMID: 39519233 PMC: 11546064. DOI: 10.3390/ijms252111681.
Beyond the cytoplasm: nuclear α-actin influences differentiation.
Gomez D Nat Cardiovasc Res. 2024; 2(10):864-866.
PMID: 39196252 DOI: 10.1038/s44161-023-00343-6.
Nuclear Smooth Muscle α-actin Participates in Vascular Smooth Muscle Cell Differentiation.
Kwartler C, Pedroza A, Kaw A, Guan P, Ma S, Duan X Nat Cardiovasc Res. 2024; 2(10):937-955.
PMID: 38919852 PMC: 11198982. DOI: 10.1038/s44161-023-00337-4.
Jain R, Epstein J Adv Exp Med Biol. 2024; 1441:341-364.
PMID: 38884720 DOI: 10.1007/978-3-031-44087-8_18.
Treatment of Thoracic SMARCA4-Deficient Undifferentiated Tumors: Where We Are and Where We Will Go.
Longo V, Catino A, Montrone M, Montagna E, Pesola F, Marech I Int J Mol Sci. 2024; 25(6).
PMID: 38542211 PMC: 10970296. DOI: 10.3390/ijms25063237.